Pacer Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Pacer Advisors's HALO Position: Q2 2026 in Review
Pacer Advisors reduced its Halozyme (HALO) stake by 23% in Q2 2026, selling an estimated $4.6M and leaving 228,060 shares worth $17.9M. The position accounts for 0.05% of the portfolio, ranked #375.
Pacer Advisors first reported a position in HALO in Q4 2017 and has held it in 24 quarters since. The position peaked at $63.1M in Q4 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Pacer Advisors held 228,060 shares of Halozyme worth $17.9M as of Q2 2026.
- Pacer Advisors sold 67,464 Halozyme shares in Q2 2026, an estimated $4.6M.
- Halozyme made up 0.05% of Pacer Advisors's portfolio in Q2 2026, its #375 holding.
- Pacer Advisors first reported a position in Halozyme in Q4 2017 and has held it in 24 quarters since.
- Pacer Advisors's Halozyme position peaked at $63.1M in Q4 2025.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.